Petch L - Search Results

1

Protease inhibitor and nonnucleoside reverse transcriptase inhibitor concentrations in the genital tract of HIV-1-infected women.

Min SS, Corbett AH, Rezk N, Cu-Uvin S, Fiscus SA, Petch L, Cohen MS, Kashuba AD. Min SS, et al. Among authors: petch l. J Acquir Immune Defic Syndr. 2004 Dec 15;37(5):1577-80. doi: 10.1097/00126334-200412150-00008. J Acquir Immune Defic Syndr. 2004. PMID: 15577412

2

Genotypic analysis of the protease and reverse transcriptase of HIV type 1 subtype C isolates from antiretroviral drug-naive adults in Malawi.

Petch LA, Hoffman IF, Jere CS, Kazembe PN, Martinson FE, Chilongozi D, Fiscus SA, Cohen MS. Petch LA, et al. AIDS Res Hum Retroviruses. 2005 Sep;21(9):799-805. doi: 10.1089/aid.2005.21.799. AIDS Res Hum Retroviruses. 2005. PMID: 16218804

3

Pharmacokinetic and pharmacodynamic investigation of efavirenz in the semen and blood of human immunodeficiency virus type 1-infected men.

Reddy YS, Gotzkowsky SK, Eron JJ, Kim JY, Fiske WD, Fiscus SA, Petch L, Cohen MS, Kashuba AD. Reddy YS, et al. Among authors: petch l. J Infect Dis. 2002 Nov 1;186(9):1339-43. doi: 10.1086/344311. Epub 2002 Oct 7. J Infect Dis. 2002. PMID: 12402205 Clinical Trial.

4

Genotypic susceptibility scores and HIV type 1 RNA responses in treatment-experienced subjects with HIV type 1 infection.

Anderson JA, Jiang H, Ding X, Petch L, Journigan T, Fiscus SA, Haubrich R, Katzenstein D, Swanstrom R, Gulick RM; AIDS Clinical Trials Group Study 359 Protocol Team. Anderson JA, et al. Among authors: petch l. AIDS Res Hum Retroviruses. 2008 May;24(5):685-94. doi: 10.1089/aid.2007.0127. AIDS Res Hum Retroviruses. 2008. PMID: 18462083 Free PMC article. Clinical Trial.

5

The effect of lamivudine therapy and M184V on the antiretroviral activity of didanosine.

Eron JJ Jr, Bosch RJ, Bettendorf D, Petch L, Fiscus S, Frank I; Adult Clinical Trials Group 307 Protocol Team. Eron JJ Jr, et al. Among authors: petch l. J Acquir Immune Defic Syndr. 2007 Jun 1;45(2):249-51. doi: 10.1097/QAI.0b013e318050d61f. J Acquir Immune Defic Syndr. 2007. PMID: 17527095 Clinical Trial. No abstract available.

6

Baseline resistance to nucleoside reverse transcriptase inhibitors fails to predict virologic response to combination therapy in children (PACTG 338).

Fiscus SA, Kovacs A, Petch LA, Hu C, Wiznia AA, Mofenson LM, Yogev R, McIntosh K, Pelton SI, Napravnik S, Stanley K, Nachman SA. Fiscus SA, et al. Among authors: petch la. AIDS Res Ther. 2007 Feb 6;4:2. doi: 10.1186/1742-6405-4-2. AIDS Res Ther. 2007. PMID: 17280617 Free PMC article.

7

Non-nucleoside phenotypic hypersusceptibility cut-point determination from ACTG 359.

Haubrich RH, Jiang H, Swanstrom R, Bates M, Katzenstein D, Petch L, Fletcher CV, Fiscus SA, Gulick RM; AIDS Clinical Trials Group Protocol 359 Team. Haubrich RH, et al. Among authors: petch l. HIV Clin Trials. 2007 Mar-Apr;8(2):63-7. doi: 10.1310/hct0802-63. HIV Clin Trials. 2007. PMID: 17507321 Clinical Trial.

8

E-cadherin engagement stimulates tyrosine phosphorylation.

Kinch MS, Petch L, Zhong C, Burridge K. Kinch MS, et al. Among authors: petch l. Cell Adhes Commun. 1997 Mar;4(6):425-37. doi: 10.3109/15419069709004459. Cell Adhes Commun. 1997. PMID: 9177904

9

Integrin engagement suppresses RhoA activity via a c-Src-dependent mechanism.

Arthur WT, Petch LA, Burridge K. Arthur WT, et al. Among authors: petch la. Curr Biol. 2000 Jun 15;10(12):719-22. doi: 10.1016/s0960-9822(00)00537-6. Curr Biol. 2000. PMID: 10873807 Free article.

10

Adhesion-induced tyrosine phosphorylation of the p130 src substrate.

Petch LA, Bockholt SM, Bouton A, Parsons JT, Burridge K. Petch LA, et al. J Cell Sci. 1995 Apr;108 ( Pt 4):1371-9. doi: 10.1242/jcs.108.4.1371. J Cell Sci. 1995. PMID: 7542255

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page